Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPRI-CF113 phase III trial in endometriosis-associated pelvic pain
2021-001424-17Phase 3Completed
- Sponsor
- Chemo
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in endometriosis comparing Drospirenone blinded arm with Placebo blinded arm (2 arms). Primary endpoint: Change from baseline in endometriosis-associated pelvic pain. Started May 2021; status: completed.
02
Drugs
drospirenone
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2021-001424-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001424-17.